Paul Y. Song, MD is a highly skilled and experienced radiation oncologist with a diverse portfolio in biotechnology and medical industries. He graduated from the University of Chicago with honors in Biological Sciences and went on to study medicine at the George Washington University School of Medicine and Health Sciences. With a strong focus on translational medicine, clinical trials, regulatory affairs, oncology, immunology, governmental affairs, therapeutic development, and healthcare policy, Dr. Song has served at executive positions in several leading companies, including Calyx Peak Companies, NKMax America Inc., Cynvenio Biosystems Inc., and BERG Health. Dr. Song also serves as a Senior Medical Advisor at Hawkeye Bio Inc. and has held several attending staff positions at leading medical centers. He is a respected thought leader in the medical industry and has contributed significantly to advancing cancer treatment and care.